Novel Induction of CD40 Expression by Tumor Cells with RAS/RAF/PI3K Pathway Inhibition Augments Response to Checkpoint Blockade

Expression of CD40 by melanoma cells was associated with therapeutic response to RAF/MEK inhibition and immune checkpoint blockade.